Amaryl: Uses, Dosage & Safety Information

Amaryl

Amaryl

Amaryl

Glimepiride
Original sulfonylurea brand cleared in 1995 and now discontinued, replaced by generics for grown-ups whose blood sugar runs high. It lowers glucose by releasing insulin, so lows are the key risk, and a trial in young people favoured another drug.
  • ActiveIngredient: Glimepiride
  • DosageForm: Tablet
  • Dosage: 1 mg, 2 mg, 4 mg
  • Indications: Type 2 diabetes mellitus
  • Manufacturer: Multiple ANDA holders
  • Storage: 20–25°C (68–77°F)
  • Drug Status: Discontinued

What is Amaryl?

Amaryl was the original brand of glimepiride, a sulfonylurea that lowers blood sugar by stimulating insulin release in adults with type 2 diabetes. The Amaryl brand, approved in 1995, is listed as discontinued, and generic glimepiride tablets are now supplied instead. Its main risk is low blood sugar. In a paediatric trial it did not match metformin, and it is advised against in children.1

Amaryl brand discontinued; generics available
Amaryl tablets (NDA 020496, approved November 1995) are listed as discontinued; generic glimepiride tablets remain FDA-approved, and glimepiride is also combined with pioglitazone in Duetact.2

Approved products and generic therapeutic-equivalence ratings are listed in the FDA Orange Book.3

In a 24-week paediatric trial, 272 children aged 8 to 17 with type 2 diabetes were randomised to glimepiride or metformin; the difference in HbA1c favoured metformin, and the trial did not meet its goal of showing a similar reduction.1

Both children new to treatment and those switching from other diabetes tablets took part, and the latter stopped their previous medicine before randomisation without a washout period.

Glimepiride is advised against in children because of adverse effects on body weight and low blood sugar seen in paediatric studies.

In a three-month titration study in people with kidney impairment, with creatinine clearance of 10 to 60 mL/min, the findings supported starting all such patients at the lowest dose.

Like other sulfonylureas, glimepiride carries a labelled warning about a possible increase in cardiovascular mortality.

Amaryl is one of the diabetes medicines; Duetact pairs glimepiride with pioglitazone.

How to Take Amaryl

Generic replacement

If your pharmacy switches you from Amaryl to generic glimepiride, the strength printed on the label should match your previous dose.1

Morning dose

Take your dose with breakfast or the first main meal of the day.

Know the lows

Shaking, sweating, hunger and confusion can mean low blood sugar; take fast-acting sugar and recheck your level.

Sulfa allergy

Tell your prescriber about any past reaction to sulfa antibiotics or similar medicines.

Colesevelam timing

Take glimepiride at least four hours before colesevelam.

Exercise and missed meals

Unplanned exercise, skipping meals can bring on low blood sugar; check your levels more often on those days.

Before driving

Check your blood sugar before you drive, and do not drive if it is low.

Skin and allergy warning signs

Seek care urgently for a blistering rash, swollen face or lips, or trouble breathing.

Pale skin or dark urine

Unusual tiredness, pale skin or dark urine can signal red-cell breakdown, especially in G6PD deficiency; tell your doctor.

What Are the Side Effects of Amaryl?

Low blood sugar is the reaction that matters most with Amaryl; in placebo-controlled studies, headache, nausea, dizziness and accidental injury were the other events reported a little more often than with placebo.

Glimepiride (Amaryl): Trial AEs
FrequencyEffectNotes
Common — 4% at 1 mg (placebo 0%)Possible hypoglycaemia at the lowest dose14-week trial
Very common — 16–17% at 4–8 mgPossible hypoglycaemia at higher doses14-week trial
Common — 5.0% (placebo 2.4%)DizzinessPooled trials
Common — 5.0% (placebo 3.4%)NauseaPooled trials
Common — 5.8% (placebo 3.4%)Accidental injuryPooled trials

Source: 1

Seek immediate medical attention if:
  • Confusion, seizures or loss of consciousness from low blood sugar
  • Blistering rash, facial swelling or difficulty breathing
  • Pale skin, unusual tiredness or dark urine
  • Yellowing of the skin or eyes
Clinical details

In the paediatric trial, glimepiride was associated with adverse effects on body weight and more low blood sugar, which is why it is advised against in children.

What is Amaryl Used For?

Glimepiride, the ingredient of Amaryl, is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes; it is not for type 1 diabetes or diabetic ketoacidosis.1

Moving from Amaryl to a generic

Generic glimepiride tablets come in the same three strengths that Amaryl used, and the same once-daily regimen with breakfast or the first main meal applies.

Kidney impairment and older adults

To limit low blood sugar, everyone with kidney impairment starts at the lowest dose, and older adults are dosed conservatively because they are more prone to hypoglycaemia; trials found no overall differences in safety or effectiveness by age.

Combining with other medicines

Glimepiride can be combined with metformin, insulin or other diabetes medicines, but low blood sugar becomes more likely, and doses may need lowering. Switching from a long-acting sulfonylurea can cause overlapping effects for one to two weeks.

Pregnancy

Sulfonylureas cross the placenta and have been linked to low blood sugar in newborns, so treatment near delivery is reviewed with the prescriber.

Children

In a 24-week trial against metformin in 272 children aged 8 to 17, glimepiride did not show a similar HbA1c reduction, and it is advised against in children.

Interactions Alcohol:

Consult your doctor
Alcohol can affect blood sugar; ask your doctor how much is safe.

Interactions Other Medications:

Use with caution
Miconazole, CYP2C9 drugs, colesevelam and other diabetes medicines interact.

Special Groups Pregnancy:

Consult your doctor
Newborns exposed near delivery may have low blood sugar; discuss with your doctor.

Special Groups Breastfeeding:

Use with caution
Breastfed infants should be monitored for low blood sugar.

Special Groups Elderly:

Use with caution
Older adults start at the lowest dose because of hypoglycaemia risk.

Special Groups Children:

Unsafe
A paediatric trial did not show benefit similar to metformin; advised against.

Effects on Activities Driving:

Use with caution
Low blood sugar can impair driving; check your sugar first.

Effects on Activities Operating Machinery:

Use with caution
Do not operate dangerous machinery if you feel shaky or confused.

A paediatric trial that did not succeed

Against metformin in 272 children, glimepiride did not show a similar HbA1c reduction and was linked to weight and low-blood-sugar problems, so its use is limited to adults.1

Low blood sugar in kidney impairment

Everyone with kidney impairment starts at the lowest dose, because the risk of hypoglycaemia is higher.

Brand discontinued

Amaryl is listed as discontinued, so glimepiride is dispensed as generic tablets, which must be bioequivalent to their reference product.4

Where it comes from

Glimepiride is prescription-only in the US; the FDA’s BeSafeRx guidance lists four signs of a lawful pharmacy website.5

Critical Warnings for Amaryl Use

Contraindications

Glimepiride is contraindicated with a history of hypersensitivity to glimepiride, its ingredients or sulfonamide derivatives.1

Hypoglycaemia

Severe low blood sugar can occur, especially in older adults, people with kidney impairment and with other diabetes medicines.

Hypersensitivity

Anaphylaxis, angioedema and Stevens-Johnson syndrome have been reported after marketing; glimepiride is stopped promptly and another treatment chosen if a reaction is suspected.

Haemolytic anaemia

People with G6PD deficiency can develop haemolytic anaemia on sulfonylureas such as glimepiride, so a non-sulfonylurea alternative is considered for them.

Cardiovascular mortality

A possible increase in cardiovascular mortality is labelled for sulfonylureas.

See Interactions for the full list of drug combinations.

Dosage

Amaryl Products
FormulationActive IngredientsClinical Note
Tablets (generic)Glimepiride1, 2, 4 mg
StartGlimepiride1 or 2 mg once daily with breakfast
TitrationGlimepiride1–2 mg steps every 1–2 weeks; maximum 8 mg/day
Kidney impairment; older adultsGlimepirideStart 1 mg
From long-acting sulfonylureasGlimepirideMonitor 1–2 weeks for overlap
Liver impairmentGlimepirideNo specific adjustment in the labelling

Source: 1

Exceeding the dose
Overdose can cause severe low blood sugar; mild episodes are treated with oral glucose, while coma or seizures need glucagon or intravenous glucose and prolonged observation, as low blood sugar may recur.1

Marketed strengths and their labelers are listed in the FDA National Drug Code Directory.6

What Does Amaryl Interact With?

Interactions by Severity
Interacting SubstanceEffect and RiskSeverityDocumentation
Oral miconazoleSevere hypoglycaemiaMajorGood — labelled
CYP2C9 inhibitors and inducersAltered glimepiride levelsModerateGood — labelled
ColesevelamReduced absorption; separate by 4 hoursModerateGood — labelled
Other glucose-lowering drugsGreater glucose loweringModerateGood — labelled

Source: 1

The Amaryl brand of glimepiride, approved in 1995, is listed as discontinued, but generic glimepiride tablets remain FDA-approved in 1, 2 and 4 mg strengths. Generics must contain the same active ingredient and be bioequivalent to the reference product. If your pharmacy switches you to a generic, check that the strength on the label matches your previous dose.
No. In a 24-week trial, 272 children aged 8 to 17 with type 2 diabetes were randomised to glimepiride or metformin, and glimepiride did not show a similar HbA1c reduction. Paediatric studies also showed adverse effects on body weight and more low blood sugar. For these reasons glimepiride is advised against in children, and prescribers choose other medicines.
Glimepiride, the ingredient of Amaryl, is taken once a day with breakfast or the first main meal. It usually starts at 1 or 2 mg and rises in 1–2 mg steps every one to two weeks, up to 8 mg a day. People with kidney impairment and older adults start at 1 mg because they are more prone to low blood sugar.
Yes. Low blood sugar is the main risk of Amaryl and generic glimepiride: in a 14-week trial, possible hypoglycaemia was reported by 4% at 1 mg and 16–17% at 4–8 mg, versus none on placebo. It is more likely with skipped meals, exercise, kidney impairment, older age and other diabetes medicines. Keep a fast-acting sugar source with you and check before driving.
Yes. Glimepiride is combined with pioglitazone in the brand Duetact, and it can be taken alongside metformin, insulin or other diabetes medicines. Combining glucose-lowering drugs makes low blood sugar more likely, so doses may need lowering. Oral miconazole can cause severe low blood sugar with glimepiride, and colesevelam should be taken at least four hours later.

Evidence scope

What we know
  • Amaryl was approved in 1995 and is now discontinued.
  • A paediatric trial of 272 children did not show results similar to metformin.
  • People with kidney impairment start at the lowest dose.
  • Possible hypoglycaemia affected 16–17% at higher doses.
What remains uncertain
  • Whether glimepiride passes into human milk.
  • Whether it reduces heart attacks or strokes; no study has shown this.
  • Long-term effects in children, as it is not used in that group.

Source: 1

What has been reported to the FDA

Reports to the FDA naming glimepiride are summarised on the glimepiride page.7

Who was this medicine studied in?

About 2,800 adults received glimepiride in controlled trials, and a 24-week paediatric trial randomised 272 children.1

Who this is and is not appropriate for

Not for type 1 diabetes, diabetic ketoacidosis, sulfonamide allergy, or children.

Adults with type 2 diabetes switching from Amaryl to generic glimepiride or starting a sulfonylurea.

Where to report and verify

Routing to Official Registries
What you needWhere to go
Report a side effectFDA MedWatch
Pregnancy-specific dataMotherToBaby
Full prescribing informationDailyMed
Verify a pharmacy websiteFDA BeSafeRx · LegitScript

References

  1. FDA label, Glimepiride Tablets USP 1, 2, 4 mg (Aurobindo Pharma; ANDA 202759)
    Revised 2026-03 · Accessed 2026-10-24
    Used for: indication, dosing incl. kidney and older adults, contraindications, warnings, adverse reactions, interactions, paediatric trial, renal study, overdose.
    dailymed.nlm.nih.gov — glimepiride SPL
  2. Drugs@FDA
    Record accessed 2026-10-24
    Used for: application and marketing status.
    accessdata.fda.gov — Drugs@FDA
  3. FDA Orange Book
    Accessed 2026-10-24
    Used for: reference and generic listings.
    accessdata.fda.gov — Orange Book
  4. FDA — Generic Drugs: Questions & Answers
    Accessed 2026-10-24
    Used for: requirements for generic equivalence (same active ingredient, strength, bioequivalence).
    fda.gov — Generic Drugs Q&A
  5. FDA BeSafeRx — signs of a safe pharmacy website (flyer)
    Accessed 2026-10-24
    Used for: four signs of a lawful pharmacy website.
    fda.gov — BeSafeRx
  6. FDA National Drug Code Directory
    Directory accessed 2026-10-24
    Used for: marketed products and strengths.
    accessdata.fda.gov — NDC Directory
  7. FDA Adverse Event Reporting System (openFDA)
    Data cut 2026-07-30 · Accessed 2026-10-24
    Used for: report totals and the ten most frequent terms.
    open.fda.gov — drug adverse event API

How this page was sourced

Clinical facts come from current FDA labelling for generic glimepiride tablets, the ingredient of Amaryl.

Brand status comes from Drugs@FDA; the report summary is on the glimepiride page.

Disclaimer: The information on this site is provided for informational purposes only and is not medical advice. It does not replace professional medical consultation, diagnosis, or treatment. Do not self-medicate based on the information presented on this site. Always consult with a doctor or other qualified healthcare professional before making any decisions about your health.